Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12

被引:175
作者
Yao, L
Sgadari, C
Furuke, K
Bloom, ET
Teruya-Feldstein, J
Tosato, G
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Hematol Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Hematopathol Sect, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V93.5.1612.405a13_1612_1621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induced angiogenesis in athymic mice. By immunohistochemistry, those sites where bFGF-induced neovascularization was inhibited by IL-12 displayed accumulation of NK cells and the presence of IP-10-positive cells. Based on expression of the cytolytic mediators perforin and granzyme B, the NK cells were locally activated. Experimental Burkitt lymphomas treated locally with IL-12 displayed tumor tissue necrosis, vascular damage, and NK-cell infiltration surrounding small vessels. After activation in vitro with IL-12 NK cells from nude mice became strongly cytotoxic for primary cultures of syngeneic aortic endothelial cells. Cytotoxicity was neutralized by antibodies to IFN-gamma. These results document that NK cells are required mediators of angiogenesis inhibition by IL-12 and provide evidence that NK-cell cytotoxicity of endothelial cells is a potential mechanism by which IL-12 can suppress neovascularization.
引用
收藏
页码:1612 / 1621
页数:10
相关论文
共 53 条
  • [1] MOLECULES AND STRUCTURES INVOLVED IN THE ADHESION OF NATURAL-KILLER-CELLS TO VASCULAR ENDOTHELIUM
    ALLAVENA, P
    PAGANIN, C
    MARTINPADURA, I
    PERI, G
    GABOLI, M
    DEJANA, E
    MARCHISIO, PC
    MANTOVANI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) : 439 - 448
  • [2] HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO
    ANGIOLILLO, AL
    SGADARI, C
    TAUB, DD
    LIAO, F
    FARBER, JM
    MAHESHWARI, S
    KLEINMAN, HK
    REAMAN, GH
    TOSATO, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 155 - 162
  • [3] Interleukin-15 promotes angiogenesis in vivo
    Angiolillo, AL
    Kanegane, H
    Sgadari, C
    Reaman, GH
    Tosato, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) : 231 - 237
  • [4] BALLAS ZK, 1993, J IMMUNOL, V150, P17
  • [5] BARIOZZARI T, 1985, J IMMUNOL, V134, P2783
  • [6] Borgstrom P, 1996, CANCER RES, V56, P4032
  • [7] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS
    BROOKS, PC
    MONTGOMERY, AMP
    ROSENFELD, M
    REISFELD, RA
    HU, TH
    KLIER, G
    CHERESH, DA
    [J]. CELL, 1994, 79 (07) : 1157 - 1164
  • [8] ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS
    BRUNDA, MJ
    LUISTRO, L
    WARRIER, RR
    WRIGHT, RB
    HUBBARD, BR
    MURPHY, M
    WOLF, SF
    GATELY, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) : 1223 - 1230
  • [9] DAMLE NK, 1987, J IMMUNOL, V138, P1779
  • [10] DAMLE NK, 1989, J IMMUNOL, V142, P2660